Pooled analysis of the prognostic relevance of disseminated tumor cells in the bone marrow of patients with ovarian cancer

International Journal of Gynecological Cancer

Volumn 23, Issue 5, 2013, Pages 839-845

  Fehm, Tanja ^a,j   Banys, Malgorzata ^b,c   Rack, Brigitte ^d   Janni, Wolfgang ^e   Marth, Christian ^f   Blassl, Christina ^b   Hartkopf, Andreas ^b   Trope, Claes ^g   Kimmig, Rainer ^h   Krawczyk, Natalia ^a   Wallwiener, Diethelm ^b   Wimberger, Pauline ⁱ   Kasimir Bauer, Sabine ⁱ  

^a UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

^b UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^c Marien Krankenhaus Hamburg   (Germany)

^d LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^e UNIVERSITY HOSPITAL ULM   (Germany)

^f INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^g OSLO UNIVERSITY HOSPITAL   (Norway)

^h UNIVERSITY HOSPITAL ESSEN   (Germany)

ⁱ UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^j HEINRICH HEINE UNIVERSITY   (Germany)

more..

Author keywords

Bone marrow; Disseminated tumor cells; Ovarian cancer; Overall survival; Progression free survival

Indexed keywords

ANTIBODY; TUMOR MARKER;

ADULT; AGED; ARTICLE; BONE MARROW BIOPSY; BONE MARROW METASTASIS; CANCER PROGNOSIS; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CELL STRUCTURE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; OVARY CANCER; OVERALL SURVIVAL; PATIENT MONITORING; PRIMARY TUMOR; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; PROSPECTIVE STUDY; STAINING; TREATMENT OUTCOME; TUMOR CELL;

ADENOCARCINOMA, CLEAR CELL; ADENOCARCINOMA, MUCINOUS; ADULT; AGED; AGED, 80 AND OVER; BONE MARROW NEOPLASMS; CYSTADENOCARCINOMA, SEROUS; ENDOMETRIAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; OVARIAN NEOPLASMS; PROGNOSIS; PROSPECTIVE STUDIES; SURVIVAL RATE; YOUNG ADULT;

EID: 84880446324     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1097/IGC.0b013e3182907109     Document Type: Article

References (24)

1. Ries LAG, Harkins D, Krapcho M, et al. SEER Cancer Statistics Review, 1975-2003. Bethesda, MD: National Cancer Institute; 2006.
2. Cannistra SA. Cancer of the ovary. N Engl J Med. 2004;351:2519-2529.
3. Braun S, Vogl FD, Naume B, et al. A pooled analysis of bone marrow micrometastasis in breast cancer. N Engl J Med. 2005;353:793-802.
4. Banys M, Solomayer EF, Becker S, et al. Disseminated tumor cells in bone marrow may affect prognosis of patients with gynecologic malignancies. Int J Gynecol Cancer. 2009;19:948-952.
5. Braun S, Schindlbeck C, Hepp F, et al. Occult tumor cells in bone marrow of patients with locoregionally restricted ovarian cancer predict early distant metastatic relapse. J Clin Oncol. 2001;19:368-375.
6. Aktas B, Kasimir-Bauer S, Heubner M, et al. Molecular profiling and prognostic relevance of circulating tumor cells in the blood of ovarian cancer patients at primary diagnosis and after platinum-based chemotherapy. Int J Gynecol Cancer. 2011;21:822-830.
7. Poveda A, Kaye SB, McCormack R, et al. Circulating tumor cells predict progression-free survival and overall survival in patients with relapsed/recurrent advanced ovarian cancer. Gynecol Oncol. 2011;122:567-572.
8. Schindlbeck C, Hantschmann P, Zerzer M, et al. Prognostic impact of KI67, p53, human epithelial growth factor receptor 2, topoisomerase IIalpha, epidermal growth factor receptor, and nm23 expression of ovarian carcinomas and disseminated tumor cells in the bone marrow. Int J Gynecol Cancer. 2007;17:1047-1055.
9. Fehm T, Becker S, Bachmann C, et al. Detection of disseminated tumor cells in patients with gynecological cancers. Gynecol Oncol. 2006;103:942-947.
10. Dauplat J, Hacker NF, Nieberg RK, et al. Distant metastases in epithelial ovarian carcinoma. Cancer. 1987;60:1561-1566.
11. Fehm T, Braun S, Muller V, et al. A concept for the standardized detection of disseminated tumor cells in bone marrow from patients with primary breast cancer and its clinical implementation. Cancer. 2006;107:885-892.
12. Wimberger P, Heubner M, Otterbach F, et al. Influence of platinum-based chemotherapy on disseminated tumor cells in blood and bone marrow of patients with ovarian cancer. Gynecol Oncol. 2007;107:331-338.
13. Marth C, Kisic J, Kaern J, et al. Circulating tumor cells in the peripheral blood and bone marrow of patients with ovarian carcinoma do not predict prognosis. Cancer. 2002;94:707-712.
14. Wimberger P, Roth C, Pantel K, et al. Impact of platinum-based chemotherapy on circulating nucleic acid levels, protease activities in blood and disseminated tumor cells in bone marrow of ovarian cancer patients. Int J Cancer. 2011;128:2572-2580.
15. Fan T, Zhao Q, Chen JJ, et al. Clinical significance of circulating tumor cells detected by an invasion assay in peripheral blood of patients with ovarian cancer. Gynecol Oncol. 2009;112:185-191.
16. Heubner M, Wimberger P, Dahlmann B, et al. The prognostic impact of circulating proteasome concentrations in patients with epithelial ovarian cancer. Gynecol Oncol. 2011;120:233-238.
17. Cain JM, Ellis GK, Collins C, et al. Bone marrow involvement in epithelial ovarian cancer by immunocytochemical assessment. Gynecol Oncol. 1990;38:442-445.
18. Camara O, Kavallaris A, Noschel H, et al. Seeding of epithelial cells into circulation during surgery for breast cancer: The fate of malignant and benign mobilized cells. World J Surg Oncol. 2006;4:67.
19. Dyall S, Gayther SA, Dafou D. Cancer stem cells and epithelial ovarian cancer. J Oncol. 2010;2010:105269.
20. Setoguchi T, Taga T, Kondo T. Cancer stem cells persist in many cancer cell lines. Cell Cycle. 2004;3:414-415.
21. Szotek PP, Pieretti-Vanmarcke R, Masiakos PT, et al. Ovarian cancer side population defines cells with stem cell-like characteristics and Mullerian inhibiting substance responsiveness. Proc Natl Acad Sci U S A. 2006;103:11154-11159.
22. Hosonuma S, Kobayashi Y, Kojo S, et al. Clinical significance of side population in ovarian cancer cells. Hum Cell. 2011;24:9-12.
23. Aktas B, Tewes M, Fehm T, et al. Stem cell and epithelial-mesenchymal transition markers are frequently overexpressed in circulating tumor cells of metastatic breast cancer patients. Breast Cancer Res. 2009;11:R46.
24. Balic M, Lin H, Young L, et al. Most early disseminated cancer cells detected in bone marrow of breast cancer patients have a putative breast cancer stem cell phenotype. Clin Cancer Res. 2006;12:5615-5621.